Xarelto (rivaroxaban) and Eliquis (apixaban) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat or help prevent blood clots in certain ...

Dec 21 (Reuters) - Older adults taking Bayer AG's (BAYGn.DE), opens new tab blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious ...

(CBS/AP) The FDA has approved a "next generation" blood thinner called Xarelto for the treatment of atrial fibrillation, a common heart disorder that can lead to stroke. Atrial fibrillation, a.k.a.

A new oral suspension formulation of Xarelto has also been approved by the FDA. The Food and Drug Administration (FDA) has approved Xarelto ® (rivaroxaban) for 2 new pediatric indications: treatment ...

The FDA has approved Xarelto (rivaroxaban; Janssen) for the prophylaxis of venous thromboembolism (VTE) and VTE-related death during hospitalization and post hospital discharge in adult patients ...

The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial ...

Janssen, a subsidiary of Johnson & Johnson JNJ, announced that the FDA has approved the label expansion of its blood thinner, Xarelto. The drug is now approved for reduction in risk of major ...